You're signed outSign in or to get full access.
About
Eric Song, PhD, is a Research Analyst at Sio Capital Management LLC in New York, where he has been with the firm since 2018. At Sio Capital, he specializes in the therapeutics sector, leveraging his scientific expertise to identify and analyze investment opportunities specifically within therapeutics and biotechnology.
Before joining Sio Capital, Eric was a sell-side Research Associate at Raymond James, focusing on biotechnology equities, and previously managed a personal investment portfolio emphasizing value-oriented strategies in biotech stocks. His unique background bridges rigorous academic training and practical investment experience in life sciences.
Eric holds a Ph.D. in Molecular and Cellular Pharmacology from the University of Miami and an undergraduate degree in Clinical Pharmacology from Shenyang Pharmaceutical University. His deep technical knowledge and sector specialization make him a valuable contributor to Sio Capital’s healthcare-focused, equity market neutral investment approach.
Career History
| Organization | Role | Date Range | Details |
|---|---|---|---|
| Sio Capital Management LLC | Analyst | Jan 2018 to Present | — |
| Raymond James | Equity Research Associate | Jan 2017 to Jan 2018 | — |
| Self-Employed | Investor | Jan 2016 to Jan 2017 | — |
| Diabetes Research Institute Foundation | Graduate Research Fellow | Jan 2009 to Jan 2016 | — |
Others at Sio Capital Management, LLC (8)
| Name | Role | Location |
|---|---|---|
 | Analyst | New Haven, CT , United States |
M Mansi Sanghvi | Principal | United States |
 | Portfolio Manager and Managing Director | New York, NY , United States |
 | Research Analyst | Edgewater, NJ , United States |
 | Senior Research Analyst | Mississauga, ON , Canada |
 | Analyst | Toronto, ON , Canada |
U Usman Hassan | Analyst | New York, NY , United States |
V Vladimir Vasilyev | Healthcare Analyst | New York, NY , United States |
